Thank you very much! I am still hoping for progress regarding birch pollen. That should be much closer to some money than the SARS-CoV-2 vaccine projects. Perhaps MYMX has also potential because of its cold chain independent delivery system - BioNTech's CEO said their vaccine is almost perfect, but they need cold storage. But that's only hopes. The birch pollen project is much further. If I take in account the number of press releases that cooperation with Anergis and Mymetics is not only one among many to Stallergenes Greer. I would like to know how successful the tests were - only a bit or really successful.